Conference Main Scientific Topics:
• Diagnosis and treatment of rare diseases
• Novel treatments
• Dilemmas in AML
• Debate: MRD conversion before alloSCT
• Innovative trial designs to accelerate advances in leukaemia
• Immunotherapy in AML and ALL
• VenAza or intensive chemo as 1L treatment before allo HCT
• Debate: Transplant is no longer first line approach to Ph+ ALL
• Leukaemia treatment challenges
• Clonal haematopoiesis and germline predisposition
For more information, click here!
With the support of*:
Major Conference Partner
*******
Level 1 Conference Partners
*******
Level 2 Conference Partners
*******
Supporting Conference Partners
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.